№ files_lp_3_process_9_52108
File format: docx
Character count: 45255
File size: 75 KB
Structured medical bibliography compiling clinical trials, meta-analyses, practice guidelines, and reviews on immunotherapy for head and neck neoplasms identified through defined database search strategies and date limits.
Organization:
Society for Immunotherapy of Cancer
Document Type:
Bibliography
Subject:
Cancer Immunotherapy
Focus:
Head and Neck Squamous Cell Carcinoma
Publication Date:
December 17, 2018
Date Range of Literature Search:
December 1, 2013 – December 17, 2018
Search Limits:
Humans, Clinical Trial, Meta-Analysis, Practice Guideline, Randomized Controlled Trial, Review
Therapeutic Agents Covered:
Pembrolizumab, Nivolumab, Cemiplimab, Durvalumab
Biomarkers and Targets:
PD-1, PD-L1, HPV
Total References Identified:
199
Total Duplicates Removed:
42
Total Records in Bibliography:
157
Topics Included:
Immune checkpoint inhibitors, biomarkers, combination immunotherapy, adverse events, toxicity, vaccine, adjuvant and neoadjuvant immunotherapy, rare head and neck cancers
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2014
Region / city:
India
Type of document:
Original research article
Field:
Oral and maxillofacial pathology
Authors:
R Syedmukith, BR Ahmedmujib, TS Bastian
Study period:
1997–2005
Sample size:
75 patients
Age groups:
≤40 years and >40 years
Follow-up duration:
5 years
Staging system:
STNMP (site, tumor, node, metastasis, pathology)
Conflict of interest:
None
Funding:
Nil
Year:
2022
Region / City:
N/A
Topic:
Oncology, Pathology
Document Type:
Protocol
Organization:
CAP (College of American Pathologists)
Authors:
Raja R. Seethala, MD; Wonwoo Shon, DO; Bonnie L. Balzer, MD, PhD; Umamaheswar Duvvuri, MD, PhD; Nima M. Gharavi, MD, PhD; William Lydiatt, MD
Intended Audience:
Pathologists, Clinical Laboratories, Medical Institutions
Effective Period:
From March 2023
Approval Date:
September 2022
Amendment Date:
N/A
Year:
2023
Region / City:
Not specified
Topic:
Thoracic esophagectomy, survival outcomes, esophageal cancer
Document Type:
Research article
Institution:
Not specified
Author:
Not specified
Target Audience:
Medical professionals, researchers in oncology
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2026
Region:
Not specified
Research Field:
Oncology
Document Type:
Clinical study report
Institution:
Not specified
Author:
Not specified
Target Population:
ESCC patients
Study Period:
Not specified
Data Analysis Methods:
Univariate and multivariate Cox regression, Kaplan–Meier survival curves, Chi-square test
Variables Analyzed:
Age, sex, tumor location, grade, T stage, stage, primary tumor length, tumor types, lymphatic invasion, perineural invasion, lymphangio vascular invasion, postoperative chemotherapy
Survival Outcomes:
Overall survival, stratified survival by stage, lymph node status, T stage, and chemotherapy
Statistical Significance Threshold:
p < 0.05
Sample Size:
195 patients
Follow-up:
Postoperative
Year:
2026
Patient Demographics:
70-year-old white male; 68-year-old black male
Primary Site:
Left pyriform sinus; Right lateral wall of oropharynx
Histology:
Squamous cell carcinoma, invasive
Grade/Differentiation:
Moderately to poorly differentiated
Clinical Stage:
cT2 cN2b cM0 Stage IVA; cT2 N2b M0 Stage IVA
Treatment:
Chemoradiation with cisplatin, 70 Gy in 35 fractions for pyriform sinus; 60 Gy in 30 fractions for oropharynx
Imaging:
CT Neck, PET/CT, CT Larynx/Neck
Surgical Procedures:
Fine needle aspiration, transoral resection, selective neck dissection
Lymph Node Status:
Metastatic involvement in cervical and retropharyngeal nodes
Perineural and Lymphovascular Invasion:
Present in oropharyngeal tumor
Smoking Status:
Current smoker (first patient), smoker (second patient)
Alcohol Use:
Current user (first patient), history of alcohol use (second patient)
HPV Status:
Positive (first patient)
Year:
2023
Region / City:
Europe
Topic:
Allergen immunotherapy, allergic asthma, house dust mites
Document Type:
Clinical guideline
Organization / Institution:
European Academy of Allergy and Clinical Immunology (EAACI)
Authors:
I Agache, S Lau, CA Akdis, S Smolinska, M Bonini, O Cavkaytar, B Flood, P Gajdanowicz, K Izuhara, Ö Kalayci, R Mosges, O Palomares, N Papadopoulos, M Sokolowska, E Angier, M Fernandez-Rivas, G Pajno, O Pfaar, G Roberts, D Ryan, G Sturm, R van Ree, EM Varga, R Gerth van Wijk, JJ Yepes – Nuñez, M Jutel
Target Audience:
Healthcare professionals (doctors, researchers, allergy specialists)
Date Approved:
2023
Date of Revisions:
N/A
Year:
Not specified
Region / City:
Not specified
Topic:
Allergen immunotherapy billing and insurance coverage
Document Type:
Template
Organization / Institution:
Not specified
Author:
Not specified
Target Audience:
Healthcare providers, insurance companies
Period of validity:
Not specified
Approval Date:
Not specified
Date of changes:
Not specified
Year:
2023
Region / City:
Wuhan, China
Topic:
Immunology, Cancer Research, Gene Expression, Immunotherapy
Document Type:
Research Article
Institution:
Wuhan University of Science & Technology, Huazhong University of Science and Technology, Anhui Normal University
Authors:
Fei-Fei Hu, Chun-Jie Liu, Lan-Lan Liu, Qiong Zhang, An-Yuan Guo
Target Audience:
Researchers, Healthcare Professionals, Academics in Immunology and Oncology
Period of Validity:
N/A
Approval Date:
N/A
Date of Last Revision:
N/A
Journal:
World Journal of Gastrointestinal Oncology
Manuscript Number:
80135
Manuscript Type:
Review
Authors:
Ying-Zhe Luo; Hong Zhu
Author Affiliations:
Department of Medical Oncology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, China; Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China
Corresponding Author:
Hong Zhu
Funding:
The Key Research Projects of Science and Technology of Sichuan Province (No. 2022YFS0189)
Received:
September 18, 2022
Revised:
February 11, 2023
Accepted:
February 27, 2023
Published Online:
March 15, 2023
Volume and Issue:
Volume 15, Issue 3
Pages:
405-424
DOI:
10.4251/wjgo.v15.i3.405
Publisher:
Baishideng Publishing Group Inc.
Keywords:
Recurrent hepatocellular carcinoma; Immunotherapy; Immune checkpoint inhibitor; Chimeric antigen receptor-engineered T cell; Oncolytic virus; Tumor vaccine
Subject Area:
Oncology; Hepatology; Cancer Immunotherapy
Geographic Context:
Global epidemiology with reference to East and South-East Asia, United States, and Europe
Year:
2026
Region / City:
International / Multiple research institutions
Subject:
Cancer immunotherapy, tumor microenvironment
Document type:
Supplementary scientific data
Institution:
University of Southampton, Genkyotex SA, La Jolla Institute for Allergy & Immunology, University of Toronto, University of Kent
Authors:
Kirsty Ford, Christopher J. Hanley, Massimiliano Mellone, Cedric Szyndralewiez, Freddy Heitz, Philippe Wiesel, Oliver Wood, Maria Machado, Monette Lopez, Anusha-Preethi Ganesan, Chuan Wang, Ankur Chakravarthy, Tim Fenton, Emma V. King, Pandurangan Vijayanand, Christian H. Ottensmeier, Aymen Al-Shamkhani, Natalia Savelyeva, Gareth J. Thomas
Target audience:
Researchers in oncology and immunology
Data type:
Figures, tables, and experimental results
Methods:
Q-PCR, immunofluorescence, IHC, RNA sequencing, gene network analysis
Experimental models:
Murine syngeneic tumors, TC1, MC38, 4T1, BALBneuT breast tumors
Treatment tested:
NOX4 inhibition, TGF-β1 inhibition, αPD-1, αCTLA-4, macrophage depletion
Key focus:
CAF-mediated CD8 T-cell exclusion, tumor growth modulation, immunotherapy response
Supplementary content:
Figures S1–S6, Tables S1–S2
Year:
2022
Region / City:
Daejeon, Republic of Korea
Subject:
Pharmacology, Immunotherapy, Herbal Medicine
Document Type:
Supplementary Research Document
Institution:
Chungnam National University, Korea Institute of Oriental Medicine
Authors:
Sung-yoon Yang, Jin-Mu Yi, Jaemoo Chun, Seongwon Park, Tham Thi Bui, Hwi-yeol Yun, Jung-woo Chae, Mi-Kyung Jeong
Target Audience:
Researchers in pharmacology and immunotherapy
Methodologies:
LC-MS/MS, ELISA, Cytokine Assay
Compounds Analyzed:
Bojungikki-tang components, anti-PD-L1 antibody
Study Model:
Mouse serum samples
Purpose:
Assessment of pharmacokinetic interactions and biomarker quantification
Note:
Prescribing Physician
Vials:
D, E, F
Vaccine Abbreviations:
T, M, G, C, W, D, R, Cr, Mx, Dm
Baseline Measurements:
Peak Flow, Blood Pressure
Health Screen:
Yes/No
Antihistamine Use:
Yes/No
Reactions:
Local (LR), Systemic (SR)
Year:
2026
Region / City:
Shanghai, China
Topic:
Cancer immunotherapy, ovarian cancer
Document Type:
Research article with supplementary materials
Institution:
Fudan University, Obstetrics and Gynecology Hospital; Shanghai Cancer Center
Authors:
Kankan Cao, Guodong Zhang, Moran Yang, Yiying Wang, Mengdi He, Chen Zhang, Yan Huang, Jiaqi Lu, Haiou Liu
Target Audience:
Biomedical researchers, oncologists
Experimental Models:
Mouse xenografts and isografts (OVCAR-5, SKOV3, HM1, ID8agg)
Methodologies:
RNA sequencing, CCK-8 proliferation assay, BrdU incorporation, colony formation assay, migration assay, Random Forest analysis, scRNA-seq
Therapeutic Interventions:
St3gal3 inhibition, macrophage depletion, CXCR3 blocking, α2,3 sialylation targeting, dual immune checkpoint blockade (anti-PD-1, anti-CTLA-4)
Data Repositories:
GEO accession numbers GSE213219, GSE224856, GSE158937, GSE147082
Supplementary Materials:
Figures S1–S14, detailed methods, references
Institution:
Baylor College of Medicine
Department:
Otolaryngology – Head & Neck Surgery
Document type:
Course overview document
Revision date:
April 16, 2021
Academic level:
Medical students
Rotation type:
Selective rotation
Rotation duration:
Two weeks
Clinical sites:
Ben Taub General Hospital; Michael E. DeBakey Veterans Affairs Medical Center; Texas Children’s Hospital
Geographic location:
Texas Medical Center, Houston, Texas
Course prerequisites:
None
Course directors:
Sunthosh Sivam, MD
Course coordinator:
Evelyn Trevino
Educational framework:
BCM Core Competencies and Graduation Goals
Assessment methods:
Case log; evaluations; E*value student performance assessment
Related policies:
Baylor College of Medicine Teacher-Learner Compact
Year:
Not specified
Region / City:
Not specified
Theme:
Radiology, CT scans
Document Type:
Medical report
Organization / Institution:
Not specified
Author:
Dr. Vilayat Ali, Dr. Sandeep Agarwal, Dr. Annie Agarwal, Dr. Shivani Agarwal
Target Audience:
Healthcare professionals, Radiologists
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2024
Region / City:
USA
Topic:
Ice Hockey Safety Regulations
Document Type:
Guidelines
Organization:
USA Hockey
Author:
USA Hockey
Target Audience:
Officials and Coaches
Effective Period:
2024-25 Season
Approval Date:
08/01/2024
Note:
Year
Theme:
Medical Referral
Document Type:
Referral Form
Institution:
Bristol Dental Hospital
Target Audience:
Healthcare professionals
Note:
Year
Document Type:
Written Consent for Research Study
Institution / Organization:
HCMC
Author:
Dr. Uzma Samadani, Dr. Thomas Bergman
Target Audience:
Student Athletes
Year:
2024
Region / City:
Morriston Hospital, Swansea Bay University Health Board
Topic:
Hip Fracture, Frailty, Orthogeriatrics
Document Type:
Report
Organization / Institution:
Swansea Bay University Health Board
Author:
Rhodri Davies, Charlotte Le Brocq
Target Audience:
Healthcare Professionals, Hospital Management, Medical Team
Action Required:
Approval
Approval Date:
23 April 2024
Period of Action:
2024
Date of Last Update:
February 2024
Year:
2026
Type:
Educational publication
Topic:
Dermatology / Aesthetic Medicine
Author:
All rights reserved
Target audience:
Medical professionals and aesthetic practitioners
Content focus:
Facial anatomy, subcutaneous tissue, muscles, and advanced dermal filler techniques
Regions covered:
Periorificial craniofacial region, cervicofacial region, periorbital, nasal, and perioral areas
Structure focus:
Musculoaponeurotic system, SMAS, subcutaneous fat layers, facial muscles
Format:
Written and produced manual